T. Rowe Price Associates’s Stride LRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.3M Sell
355,038
-223,865
-39% -$18.2M ﹤0.01% 919
2025
Q4
$37.6M Sell
578,903
-387,699
-40% -$35.2M ﹤0.01% 895
2025
Q3
$144M Buy
966,602
+375,657
+64% +$55.1M 0.02% 534
2025
Q2
$85.8M Sell
590,945
-68,977
-10% -$9.98M 0.01% 603
2025
Q1
$83.5M Sell
659,922
-104,145
-14% -$13.2M 0.01% 585
2024
Q4
$79.4M Buy
764,067
+65,509
+9% +$6.23M 0.01% 626
2024
Q3
$59.6M Buy
698,558
+50,976
+8% +$3.94M 0.01% 707
2024
Q2
$45.7M Buy
647,582
+139,138
+27% +$9.28M 0.01% 749
2024
Q1
$32.1M Buy
508,444
+439,911
+642% +$26.5M ﹤0.01% 845
2023
Q4
$4.07M Buy
68,533
+909
+1% +$49.8K ﹤0.01% 1268
2023
Q3
$3.05M Buy
67,624
+11,251
+20% +$458K ﹤0.01% 1322
2023
Q2
$2.1M Buy
56,373
+14,329
+34% +$573K ﹤0.01% 1458
2023
Q1
$1.65M Buy
42,044
+8,979
+27% +$352K ﹤0.01% 1538
2022
Q4
$1.03M Buy
33,065
+393
+1% +$14.4K ﹤0.01% 1755
2022
Q3
$1.37M Buy
32,672
+3,266
+11% +$132K ﹤0.01% 1603
2022
Q2
$1.2M Sell
29,406
-2,065
-7% -$76.5K ﹤0.01% 1808
2022
Q1
$1.14M Buy
31,471
+4,509
+17% +$150K ﹤0.01% 1935
2021
Q4
$899K Sell
26,962
-2,091
-7% -$72.2K ﹤0.01% 2085
2021
Q3
$1.04M Buy
29,053
+111
+0.4% +$3.64K ﹤0.01% 2042
2021
Q2
$930K Buy
28,942
+1,299
+5% +$38.7K ﹤0.01% 2103
2021
Q1
$832K Buy
27,643
+6,868
+33% +$178K ﹤0.01% 2144
2020
Q4
$441K Sell
20,775
-400
-2% -$9.93K ﹤0.01% 2297
2020
Q3
$558K Buy
21,175
+8,254
+64% +$319K ﹤0.01% 2052
2020
Q2
$352K Buy
12,921
+165
+1% +$3.97K ﹤0.01% 2196
2020
Q1
$241K Sell
12,756
-2,005
-14% -$37K ﹤0.01% 2264
2019
Q4
$300K Buy
14,761
+2,602
+21% +$55.6K ﹤0.01% 2313
2019
Q3
$321K Sell
12,159
-838
-6% -$24.1K ﹤0.01% 2258
2019
Q2
$395K Buy
12,997
+1,913
+17% +$61.6K ﹤0.01% 2208
2019
Q1
$378K Buy
11,084
+110
+1% +$3.35K ﹤0.01% 2219
2018
Q4
$272K Buy
+10,974
New +$234K ﹤0.01% 2329

Other funds holding LRN

T. Rowe Price Associates's LRN Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Stride (LRN) stake by 39% in Q1 2026, selling an estimated $18.2M and leaving 355,038 shares worth $31.3M. The position accounts for ﹤0.01% of the portfolio, ranked #919.

T. Rowe Price Associates first reported a position in LRN in Q4 2018 and has held it in 30 quarters since. The position peaked at $144M in Q3 2025. 419 funds tracked by Wall St. Rank hold LRN as of Q1 2026.

  • T. Rowe Price Associates held 355,038 shares of Stride worth $31.3M as of Q1 2026.
  • T. Rowe Price Associates sold 223,865 Stride shares in Q1 2026, an estimated $18.2M.
  • Stride made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #919 holding.
  • T. Rowe Price Associates first reported a position in Stride in Q4 2018 and has held it in 30 quarters since.
  • T. Rowe Price Associates's Stride position peaked at $144M in Q3 2025.
  • 419 funds tracked by Wall St. Rank held Stride as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.